New Jersey-based Bausch Health Companies received premarket approval from the US Food and Drug Administration on 22 February for its StableVisc Ophthalmic Viscosurgical Device (OVD) – a transparent thick liquid used during cataract surgery.
On its consumer information site, the FDA says the StableVisc OVD, which is injected into the eye through a...






